Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Developing Biomarker-Supported SSD Prevention

NCT07743645 is registered in ClinicalTrials.gov with The University of Texas Health Science Center, Houston as lead sponsor.

NCT NCT07743645
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07743645 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Developing Biomarker-Supported SSD Prevention
Lead sponsor
The University of Texas Health Science Center, Houston
Phase
Not applicable
Overall status
Recruiting
Start date
September 1, 2026
Completion date
April 1, 2031
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia spectrum disorders (ssd)